New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:39 EDTALXNAlexion price target raised to $215 from $200 at Brean Capital
Brean Capital raised its price target on Alexion following the conclusion of reimbursement discussions in France. The firm raises its estimates on the agreement with the French government and continues to see Alexion as a core holding. Shares are Buy rated.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
07:52 EDTALXNAlexion says Soliris production not interrupted by FDA facility inspection
Subscribe for More Information
06:31 EDTALXNAlexion initiates multinational registration trial of eculizumab
Subscribe for More Information
August 18, 2014
07:57 EDTALXNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use